Gadofosveset Trisodium (Vasovist) is a safe and well tolerated intravascular contrast agent, currently approved in Europe and Canada. It has proved to be effective in the asessment of vascular diseases at all vascular territories. The possibility to image at steady state opens new horizons by increasing the spatial resolution and the robustness of diagnostic MRA. Initial studies proved the possibility to image beyond the vascular territory and to assess enhancing lesions as known from studies with standard contrast agents.